Inventor
HERMINE OLIVIER
FR17 patents
⚠️ This page may combine multiple inventors who share the name “HERMINE OLIVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INST NAT SANTE RECH MED
11 patentsUS7976841B2Jul 12, 2011
Anti TfR antibody
INST NAT SANTE RECH MED8 citations74
US9463217B1Oct 11, 2016
Methods and pharmaceutical compositions for treatment of retinal occlusion
INST NAT SANTE RECH MED4 citations61
US10151745B2Dec 11, 2018
Methods for determining the risk of acute graft versus host disease
INST NAT SANTE RECH MED2 citations59
US11629192B2Apr 18, 2023
Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway
INST NAT SANTE RECH MED0 citations53
US11065230B2Jul 20, 2021
Methods and pharmaceutical compositions for the treatment of systemic mastocytosis
INST NAT SANTE RECH MED0 citations49
US11389434B2Jul 19, 2022
Methods and pharmaceutical compositions for the treatment of mast cell diseases
INST NAT SANTE RECH MED0 citations48
US9107893B2Aug 18, 2015
Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
INST NAT SANTE RECH MED0 citations47
US10647752B2May 12, 2020
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1
INST NAT SANTE RECH MED0 citations40
US9377471B2Jun 28, 2016
Methods and compositions for the treatment of β-thalassemia
INST NAT SANTE RECH MED1 citations40
US12590122B2Mar 31, 2026
NRP-1 binding inhibitory peptides and uses thereof
INST NAT SANTE RECH MED0 citations39
US10111896B2Oct 30, 2018
Composition comprising a combination of DNA methylation inhibitor and a vitamin D receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse
INST NAT SANTE RECH MED0 citations36